Patents/Inventors

Penglie Zhang

Foster City, CAUS30 patents

30 Patents

US126114042026
Aza-aryl 1h-pyrazol-1-yl Benzene Sulfonamides
CHEMOCENTRYX, Inc.
0 cites
US125333542026
Triaryl Compounds for Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US124973832025
Heteroaryl-biphenyl Amides for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US124483732025
Azetidinyl-acetamides as CXCR7 Inhibitors
AMGEN Inc.
0 cites
US123714332025
Heteroaryl-biphenyl Amines for the Treatment of PD-L1 Diseases
AMGEN Inc.
0 cites
US122686752025
Diaryl Substituted 6,5-fused Ring Compounds as C5ar Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US121394752024
2-oxindole Compounds
CHEMOCENTRYX, Inc.
0 cites
US120544842024
Substituted Tetrahydropyrans as CCR2 Modulators
CHEMOCENTRYX, Inc.
0 cites
US120180162024
Aryl Sulfonyl (hydroxy) Piperidines as CCR6 Inhibitors
AMGEN Inc.
0 cites
US120124032024
Aryl Sulfonyl Compounds as CCR6 Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US120114392024
Combination Therapy Using C—C Chemokine Receptor 4 (CCR4) Antagonists and One or More Immune Checkpoint Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US119458052024
Inhibitors of CXCR2
CHEMOCENTRYX, Inc
0 cites
US118833912024
Compositions and Methods for Treating Inflammatory Bowel Disease Using CCR9 Inhibitor and Anti-il-23 Blocking Antibodies
CHEMOCENTRYX, Inc.
0 cites
US118722172024
Indanes as PD-L1 Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US118664292024
Heteroaryl-biphenyl Amines for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US118457292023
Processes and Intermediates in the Preparation of C5ar Antagonists
CHEMOCENTRYX, Inc.
0 cites
US118344522023
CXCR7 Antagonists
CHEMOCENTRYX, Inc.
0 cites
US118207592023
Modulators of Chemokine Receptors
CHEMOCENTRYX, Inc.
0 cites
US118076092023
Deuterated Compounds as Immunomodulators
CHEMOCENTRYX, Inc.
0 cites
US117937712023
Immunomodulator Compounds
CHEMOCENTRYX, Inc.
0 cites
US117730912023
6-5 Fused Rings as C5a Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US117594582023
Indane-amines as PD-L1 Antagonists
CHEMOCENTRYX, Inc.
0 cites
US117594542023
Diazole Lactams
CHEMOCENTRYX, Inc.
0 cites
US117448222023
Reducing Tumor Burden by Administering CCR1 Antagonists in Combination with PD-1 Inhibitors or PD-L1 Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US117133072023
Heteroaryl-biphenyl Amides for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US117083262023
Immunomodulator Compounds
CHEMOCENTRYX, Inc.
0 cites
US116919852023
Macrocyclic Immunomodulators
CHEMOCENTRYX, Inc.
0 cites
US116846062023
Methods of Treating Generalized Pustular Psoriasis with an Antagonist of CCR6 or CXCR2
CHEMOCENTRYX, Inc.
0 cites
US116083362023
Prodrugs of Fused-bicyclic C5ar Antagonists
CHEMOCENTRYX, Inc.
0 cites
US116033562023
Amorphous Form of a Complement Component C5a Receptor
CHEMOCENTRYX, Inc.
0 cites